Brazil’s Eurofarma invests in US biotech company
Paul Hastings LLP in São Paulo has helped Brazilian pharmaceutical company Eurofarma invest in US biotechnology group Abcuro through a US$155 million Series B financing round.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.